Presentation: Establishing a Sensitive Assay to Detect Mutations in Early Stage Endometrial Cancer

Endometrial cancer is the most common gynecologic malignancy and the fourth most common malignancy among women in the US. Furthermore, incidence is increasing and projected to surpass colorectal cancer to become the 3rd leading cancer site among U.S. women by 2030. This presentation describes a prospective study designed to test the development of an assay to detect endometrial cancer.